A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Phase 2 Recruiting 52 enrolled Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

This is an open, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets in patients with chronic graft-versus-host disease

Timeline

Start: 2024-05-07
Primary completion: 2025-10
Completion: 2026-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rovadicitinib	Small molecule	—	Oral

A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Summary

Timeline

Drugs

Indications